Back to funds
View filing
PFIZER INC
institutionalUpdated 10 days agoManaged by Pfizer Inc • Latest filing Q3 2026
Portfolio value
$164.2M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $236.5M |
| Q1 2026 | $238.8M |
| Q2 2026 | $170.4M |
| Q3 2026 | $164.2M |
Top holdings
20 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $36.4M | 22.03M | 22.13% | — | |
| 2 | $26.2M | 3.46M | 15.98% | — | |
| 3 | $23.5M | 295.7K | 14.31% | — | |
| 4 | $22.6M | 2.15M | 13.77% | — | |
| 5 | $17M | 5.95M | 10.36% | — | |
| 6 | $7.1M | 1.88M | 4.32% | — | |
| 7 | $6.6M | 505.6K | 4.00% | — | |
| 8 | ? N/A CARIBOU BIOSCIENCES INC | $5.8M | 4.69M | 3.54% | — |
| 9 | $4.9M | 372.9K | 2.99% | — | |
| 10 | $3.1M | 1.08M | 1.88% | — | |
| 11 | ? N/A CARDIFF ONCOLOGY INC | $3M | 2.41M | 1.82% | — |
| 12 | ? N/A SPERO THERAPEUTICS INC | $2.9M | 2.36M | 1.77% | — |
| 13 | ? N/A ZENTALIS PHARMACEUTICALS INC | $2.6M | 953.8K | 1.57% | — |
| 14 | $2.2M | 538.8K | 1.33% | — | |
| 15 | $190K | 37.3K | 0.12% | — | |
| 16 | ? N/A BOLT BIOTHERAPEUTICS INC | $112K | 31.3K | 0.07% | — |
| 17 | $36K | 7.0K | 0.02% | — | |
| 18 | $29K | 2.7K | 0.02% | — | |
| 19 | $22K | 2.2K | 0.01% | — | |
| 20 | $3K | 247 | 0.00% | — |